Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs
Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.
Eric Mansion | 17/07/2025 | By Mrinmoy Dey | 195
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy